5V4E
Engineered human IgG Fc domain glyco801 (Fc801)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.3 |
Synchrotron site | ALS |
Beamline | 5.0.3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-03-04 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.97648 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 93.615, 141.020, 98.866 |
Unit cell angles | 90.00, 117.33, 90.00 |
Refinement procedure
Resolution | 39.886 - 3.216 |
R-factor | 0.2384 |
Rwork | 0.236 |
R-free | 0.28090 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.003 |
RMSD bond angle | 0.614 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX ((1.10.1_2155)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.000 | 3.280 |
High resolution limit [Å] | 3.220 | 3.220 |
Rmerge | 0.150 | |
Number of reflections | 36958 | |
<I/σ(I)> | 9.692 | 1.55 |
Completeness [%] | 99.8 | |
Redundancy | 3.6 | 3.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 40 mM potassium phosphate 16% w/v PEG 8000 20% v/v glycerol |